Psych Congress 2026

Format

in-person

CME

Up to 24.75 AMA PRA Category 1 credits — ≈ $8/credit at the lowest rate; covers roughly a full year of a typical 25-hr/yr state requirement

Registration

$199 – $2,099

Official website → · Add dates & deadlines to calendar

Registration pricing

Who this conference is for

The biggest practical-psychopharmacology meeting for frontline prescribers. Sessions are treatment-decision oriented rather than mechanistic; especially strong fit for PMHNPs and community psychiatrists.

At a glance

Primary audience

Psychiatrists & NPs — Roughly half NPs/PAs, half psychiatrists; explicitly prescriber-practical

Orientation

Purely clinical

Industry funding

Heavy industry presence — Heavily industry-supported with large exhibit hall and product theaters

Typical attendance

~4,000

Program highlights

6 of 60 major sessions from the official program — excludes posters, exhibits, and social events.

• CourseAdvanced Psychopharmacology Intensive: Emerging Neurobiologic Targets and Metabolic Pathways Reshaping Psychiatric Treatment

  Brittany Albright, MD, MPH · Rakesh Jain, MD, MPH · Gregory Mattingly, MD · David Plante, MD, PhD

  Half-day ticketed intensive built around four expert-led modules on treatment mechanisms moving beyond monoamines: orexin-based agents, glutamate/dopamine circuit approaches, muscarinic receptor modulation, and GLP-1/bioenergetic pathways.

• CourseIntegrative PsychiatryIntegrative Psychiatry Intensive: Systems-Level Biology and Lifestyle Factors Transforming Psychiatric Practice

  James Greenblatt, MD · Ashley Mason, PhD · Charles Raison, MD

  Half-day ticketed intensive covering four integrative domains — temperature-based interventions, rapid sleep-optimization strategies, nutritional psychiatry, and metabolic regulation of brain function — framed as complements to standard psychopharmacology.

• DebatePsychedelicsPsychedelic Therapy After the Executive Order: Now What?

  Marcus Capone · Amber Capone · Matthew Zorn, JD · Rakesh Jain, MD, MPH · Saundra Jain, MA, PsyD, LPC · Andrew Penn, MS, PMHNP-BC · Charles Raison, MD

  Opening-afternoon multidisciplinary panel pairing a patient's lived-experience story with a policy update on how the recent executive order and existing regulatory frameworks may shape near-term clinical use of psychedelic therapies.

• LectureDifficult MedicinesDifficult Medicines: The Art and Science of Lithium Therapy

  Jonathan Meyer, MD

  Practical deep dive on lithium's mechanisms and dosing precision, including monitoring, toxicity mitigation, adherence, and use in special populations.

• SymposiumPediatric PsychiatryRethinking Pediatric Depression: Early Identification and Emerging Treatments

  Adelaide Robb, MD · Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, FAAN · Liv Lewis, Lived Experience Expert

  Reviews atypical presentations of youth depression and newer options including rapid-acting agents and digital therapeutics, with strategies for early detection in schools and primary care and a lived-experience perspective.

• SymposiumIntegrative PsychiatrySmall Changes, Big Impact: How to Bring Lifestyle and Nutritional Psychiatry into Real-World Practice

  Mariela Podolski, MD · James Somers, PA-C, DHSc, DFAAPA

  Workflow-friendly tactics for weaving sleep, exercise, stress management, social connection, and nutritional assessment into time-limited medication visits.

See the full program — all 60 sessions & speakers →

Program details verified August 20, 2026; sessions and speakers may change — confirm on the official site.

Psych Congress: past & future editions

Held over 5 days in mid-September in recent years, rotating cities.

Full Psych Congress history & future dates →